Category: VOLUME-2 /SPECIAL ISSUE-1

Hamida El Malt, W.P.M. Sewmini Volume 2 Special Issue 1 (Feb) 2025, Article 30 (pp.73-74) Key Points Question: Can ACAT1 inhibition serve as a viable therapeutic target for glioblastoma (GBM)…

Shaan Sinojia, Tatia Aprasidze Volume 2 Special Issue 1 (Feb) 2025, Article 31 (pp.75-76) Key Points Question: What are the genetic basis and clinical characteristics of Bainbridge-Ropers Syndrome (BRS)? Findings:…

Angela Thomas, Jesli Mariyem. Volume 2 Special Issue 1 (Feb) 2025, Article 32 (pp.77-78) Key Points Question: How does gut microbiota influence the progression of Multiple Sclerosis (MS)? Findings: Dybiosis…

Joan Susan Zacharia Volume 2 Special Issue 1 (Feb) 2025, Article 21 (pp.53-54) Key Points Question: What are the latest advancements in diagnosing and managing Parkinson’s Disease (PD)? How can…

Ynah Joyce Lerios Orna, Johyra Hynz Marinez Menez, Sean Amre Martico, Clarence Julianne Nunez Ligsay, Danish Martico. Volume 2 Special Issue 1 (Feb) 2025, Article 27 (pp.66-68) Key Points Question:…

Sudip Sushanto Ghosh, Bhagyashree Suresh Malabadi, Vedant Satish Suryawanshi Volume 2 Special Issue 1 (Feb) 2025, Article 26 (pp.63-65) Key Points Question: How does blood-brain barrier (BBB) dysfunction contribute to…

Farhad Islam, Onyekachi Emmanuel Anyagwa, Oluwatoyin Adalia Dairo. Volume 2 Special Issue 1 (Feb) 2025, Article 25 (pp.61-62) Key Points Question: How does pulsed laser-induced jet system (LIJS) enhance skull…

Zahraa Ajami, Youssef El Joueid. Volume 2 Special Issue 1 (Feb) 2025, Article 24 (pp.59-60) Key Points Question: What are the pathogenesis, clinical manifestations, and management strategies for intrathecal methotrexate…

Beyza Bezci, Shams Farhad. Volume 2 Special Issue 1 (Feb) 2025, Article 22 (pp.55-56) Key Points Question： What are the benefits of detecting Mild Cognitive Impairment (MCI) in an ageing…